Mycobacterium Citations List: January 2024

Literature Citations

1. Antimycobacterial, Hepatoprotective and Cytotoxicity Effects of Selected Plant Species from the Menispermaceae Family. Akande, R.T., I.M. Famuyide, A.O. Aro, S.M. Nkadimeng, T. Hlokwe, P.N. Kayoka-Kabongo, and L.J. McGaw. South African Journal of Botany, 2024. 164: p. 288-296. ISI[001138718900001].
[WOS]. TB_01_2024.

2. Synthesis, Spectroscopic and Structural Characterizations and in Vitro Antimycobacterial Activity of Silver(I) Complexes with Sulfapyridine (Spy) and Sulfamerazine (Sm). Amaral, T.C., A.D.D. Silva, G.D. Pereira, P.P. Corbi, C.S.C. Canales, F.R. Pavan, and A. Cuin. Journal of Molecular Structure, 2024. 1300: 137234. ISI[001140500900001].
[WOS]. TB_01_2024.

3. Design, Synthesis and Molecular Dynamic Studies of Novel Imidazo/Pyrido-Pyrimidine Clubbed Ethyl-1,2,3,4-Tetrahydro-4-phenylpyrimidine-5-carboxylate Derivatives as Potent Anti-tubercular Agents. Bansode, A.S., M.U.M. Siddique, H.K. Jain, and R.B. Patil. Journal of Molecular Structure, 2024. 1300: 137268. ISI[001138861100001].
[WOS]. TB_01_2024.

4. Promising Antibacterial Efficacy of Arenicin Peptides against the Emerging Opportunistic Pathogen Mycobacterium abscessus. Casanova, M., M. Maresca, I. Poncin, V. Point, H. Olleik, C. Boidin-Wichlacz, A. Tasiemski, K. Mabrouk, J.F. Cavalier, and S. Canaan. Journal of Biomedical Science, 2024. 31(1): 18. PMID[38287360]. PMCID[PMC10823733].
[PubMed]. TB_01_2024.

5. Polyphyllin II Inhibits NLPR3 Inflammasome Activation and Inflammatory Response of Mycobacterium Tuberculosis-infected Human Bronchial Epithelial Cells. Cheng, G., G. Ye, Y. Ma, and Y. Wang. Allergologia et Immunopathologia, 2024. 52(1): p. 16-23. PMID[38186190].
[PubMed]. TB_01_2024.

6. Polyphosphate kinase-1 Regulates Bacterial and Host Metabolic Pathways Involved in Pathogenesis of Mycobacterium tuberculosis. Chugh, S., P. Tiwari, C. Suri, S.K. Gupta, P. Singh, R. Bouzeyen, S. Kidwai, M. Srivastava, N.R. Rameshwaram, Y. Kumar, S. Asthana, and R. Singh. Proceedings of the National Academy of Sciences of the United States of America, 2024. 121(2): e2309664121. PMID[38170746]. PMCID[PMC10786269].
[PubMed]. TB_01_2024.

7. A Rational Approach to Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold. Das, P., S.R. Gumma, A. Nayak, S. Menghani, J.R. Mandhadi, and P.P. Prabhu. Recent Advances in Anti-Infective Drug Discovery, 2024. 19(2): p. 148-158. PMID[37723955].
[PubMed]. TB_01_2024.

8. Design, Synthesis and Antitubercular Activity of Pyrazole and Benzo[d]imidazole clubbed dihydroimidazo[1,2-a]pyrimidinones. Desai, N., J. Monapara, and A. Jethawa. Indian Journal of Chemistry, 2023. 62(11): p. 1131-1140. ISI[001108026600005].
[WOS]. TB_01_2024.

9. Synthesis, Antioxidant and Antituberculosis Evaluation of Eugenol Derivatives from Mannich Condensation. El Ghallab, Y., A. Aainouss, M.D. El Messaoudi, and S. Derfoufi. ChemistrySelect, 2024. 9(1): e202303439. ISI[001134979000001].
[WOS]. TB_01_2024.

10. Reassessing the Putative Molecular Target(S) of Potent Antitubercular 2-(Alkylsulfonyl)Acetamides. Farr, D.C., T. Haselhorst, L. Tan, J. Furness, E. Strong, I.D. Grice, N.P. West, and T.A. Houston. European Journal of Medicinal Chemistry, 2024. 264: 115983. PMID[38048695].
[PubMed]. TB_01_2024.

11. Elucidation of Unusual Biosynthesis and DnaN-targeting Mode of Action of Potent Anti-tuberculosis Antibiotics Mycoplanecins. Fu, C., Y. Liu, C. Walt, S. Rasheed, C.D. Bader, P. Lukat, M. Neuber, F.P.J. Haeckl, W. Blankenfeldt, O.V. Kalinina, and R. Müller. Nature Communications, 2024. 15(1): 791. PMID[38278788]. PMCID[PMC10817943].
[PubMed]. TB_01_2024.

12. Marine-fungi-derived Gliotoxin Promotes Autophagy to Suppress Mycobacteria tuberculosis Infection in Macrophage. Fu, J., X. Luo, M. Lin, Z. Xiao, L. Huang, J. Wang, Y. Zhu, Y. Liu, and H. Tao. Marine Drugs, 2023. 21(12): 616. PMID[38132937]. PMCID[PMC10745037].
[PubMed]. TB_01_2024.

13. The Pharmacokinetics of Cpzen-45, a Novel Anti-tuberculosis Drug, in Guinea Pigs. Garcia-Contreras, L., S.N.M. Hanif, M. Ibrahim, P. Durham, and A.J. Hickey. Pharmaceutics, 2023. 15(12): 2758. PMID[38140098]. PMCID[PMC10748184].
[PubMed]. TB_01_2024.

14. Synthesis and Biological Evaluation of Diphenyl ether-linked Quinolone Derivatives as Antibacterial Agents. Ghouse, S.M., A. Akhir, K. Sinha, G. Pawar, D. Saxena, R. Akunuri, P. Malik, A. Roy, K.K. Parida, A. Dasgupta, N.P. Kalia, V.M. Yaddanapudi, S. Chopra, and S. Nanduri. ChemistrySelect, 2023. 8(48): e202303083. ISI[001129548100001].
[WOS]. TB_01_2024.

15. Metal Catalyst-free One-pot Synthesis of Carboxamide Derivatives via Ugi-4CC Reaction and Its Anti-tubercular Study. Gondaliya, B.L., D. Sriram, S.D. Varakala, P.V. Dholaria, G.K. Dhuda, and K.M. Kapadiya. Letters in Drug Design & Discovery, 2024. 21(2): p. 226-235. ISI[001137061400009].
[WOS]. TB_01_2024.

16. "Antibacterial Properties of Nine Indium(III) Complexes of Substituted Pyrazoles/Pyrazolate and the Structural and Solution Characterization of the Mer- and Trans‑Indium(III) Complexes of 4-Me-Pzh". Herrera, S., M. Yoshinaga, and R.G. Raptis. Journal of Inorganic Biochemistry, 2024. 250: 112402. PMID[37857057].
[PubMed]. TB_01_2024.

17. Bedaquiline Is Effective in the Treatment of Mycobacterium abscessus Complex Infection. Huang, W.C., Y.W. Huang, C.Y. Yang, and H.C. Chen. European Respiratory Journal, 2023. 62: PA4068. ISI[001109120507193].
[WOS]. TB_01_2024.

18. Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl tetrazoles and 1,3,4-oxadiazoles through the Deazaflavin-dependent Nitroreductase Activation Pathway. Karabanovich, G., V. Fabiánová, A. Vocat, J. Dušek, L. Valášková, J. Stolaříková, R.R.A. Kitson, P. Pávek, K. Vávrová, K. Djaout, K. Mikušová, A.R. Baulard, S.T. Cole, J. Korduláková, and J. Roh. Journal of Medicinal Chemistry, 2024. 67(1): p. 81-109. PMID[38157261]. PMCID[PMC10788908].
[PubMed]. TB_01_2024.

19. Design, Synthesis, and Computational Characterization of Interesting Schiff Base Scaffolds as Antibacterial, Antimycobacterial, and Antifungal Agents. Maruthesh, H., M.S. Katagi, J. Samuel, and B.P. Nandeshwarappa. Russian Journal of Organic Chemistry, 2023. 59(10): p. 1783-1796. ISI[001140099100002].
[WOS]. TB_01_2024.

20. miR-4687-5p Affects Intracellular Survival of Mycobacterium tuberculosis through Its Regulation of NRAMP1 Expression in A549 Cells. Meng, C., G. Chen, Y. Liu, D. Wen, J. Cui, L. Dong, Z. Yang, H. Meng, Y. Gao, J. Feng, X. Cui, and C. Wu. Microorganisms, 2024. 12(1): 227. PMID[38276212]. PMCID[PMC10818500].
[PubMed]. TB_01_2024.

21. Optimization, Characterization, and Cytotoxicity Studies of Novel Anti-tubercular Agent-loaded Liposomal Vesicles. Obiedallah, M.M., M.A. Mironov, D.V. Belyaev, A. Ene, D.V. Vakhrusheva, S.Y. Krasnoborova, S.Y. Bershitsky, D.V. Shchepkin, A.S. Minin, R.I. Ishmetova, N.K. Ignatenko, S.G. Tolshchina, O.V. Fedorova, and G.L. Rusinov. Scientific Reports, 2024. 14(1): 524. PMID[38177202]. PMCID[PMC10766644].
[PubMed]. TB_01_2024.

22. Development of 2nd Generation Aminomethyl spectinomycins That Overcome Native Efflux in Mycobacterium abscessus. Phelps, G.A., M.N. Cheramie, D.M. Fernando, P. Selchow, C.J. Meyer, S.L. Waidyarachchi, S. Dharuman, J. Liu, M. Meuli, M.D. Molin, B.Y. Killam, P.A. Murphy, S.M. Reeve, L.A. Wilt, S.M. Anderson, L. Yang, R.B. Lee, Z.H. Temrikar, P.B. Lukka, B. Meibohm, Y.S. Polikanov, S.N. Hobbie, E.C. Böttger, P. Sander, and R.E. Lee. Proceedings of the National Academy of Sciences of the United States of America, 2024. 121(2): e2314101120. PMID[38165935]. PMCID[PMC10786304].
[PubMed]. TB_01_2024.

23. Mycothione Reductase as a Potential Target in the Fight against Mycobacterium abscessus Infections. Piller, T., L. De Vooght, Y. Gansemans, F. Van Nieuwerburgh, and P. Cos. mSphere, 2024. 9(1): e0066923. PMID[38085034]. PMCID[PMC10826361].
[PubMed]. TB_01_2024.

24. Ligand-based Virtual Screening and Biological Evaluation of Inhibitors of Mycobacterium tuberculosis H37rv. Pogodin, P.V., E.G. Salina, V.V. Semenov, M.M. Raihstat, D.S. Druzhilovskiy, D.A. Filimonov, and V.V. Poroikov. SAR and QSAR in Environmental Research, 2024. 35(1): p. 53-69. PMID[38282553].
[PubMed]. TB_01_2024.

25. Antimicrobial Peptides Grafted onto the Surface of N-Acetylcysteine-chitosan Nanoparticles Can Revitalize Drugs against Clinical Isolates of Mycobacterium tuberculosis. Primo, L., C.A. Roque-Borda, C.S. Carnero Canales, I.P. Caruso, I.O. de Lourenço, V.M.M. Colturato, R.M. Sábio, F.A. de Melo, E.F. Vicente, M. Chorilli, H. da Silva Barud, P.A. Barbugli, H. Franzyk, P.R. Hansen, and F.R. Pavan. Carbohydrate Polymers, 2024. 323: 121449. PMID[37940311].
[PubMed]. TB_01_2024.

26. Discovery of 1,2,3-Triazole Incorporated Indole-Piperazines as Potent Antitubercular Agents: Design, Synthesis, in Vitro Biological Evaluation, Molecular Docking and ADME Studies. Reddyrajula, R., U. Etikyala, V. Manga, and U. Kumar Dalimba. Bioorganic & Medicinal Chemistry, 2024. 98: 117562. PMID[38184947].
[PubMed]. TB_01_2024.

27. Structure-based Virtual Screening and in Vitro Validation of Inhibitors of Cyclic Dinucleotide Phosphodiesterases ENPP1 and CdnP. Rohilla, A., A.K. Singh, B. Koleske, G. Srikrishna, and W.R. Bishai. Microbiology Spectrum, 2024. 12(1): e0201223. PMID[38095464]. PMCID[PMC10783014].
[PubMed]. TB_01_2024.

28. Spermine Enhances the Activity of Anti-tuberculosis Drugs. Sao Emani, C. and N. Reiling. Microbiology Spectrum, 2024. 12(1): e0356823. PMID[38095461]. PMCID[PMC10782994].
[PubMed]. TB_01_2024.

29. Insights into the in-Vitro Susceptibility and Drug-Drug Interaction Profiles against Drug-resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates in Amhara, Ethiopia. Seid, A., Y. Girma, E. Dereb, M. Kassa, S. Nureddin, A. Abebe, and N. Berhane. Infection and Drug Resistance, 2024. 17: p. 89-107. PMID[38223563]. PMCID[PMC10788062].
[PubMed]. TB_01_2024.

30. Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-dihydropyridines as Antituberculostatic Agents. Seitz, L., N. Reiling, C. Vorreiter, W. Sippl, S. Kessler, and A. Hilgeroth. Medicinal Chemistry, 2024. 20(1): p. 30-39. PMID[37349995].
[PubMed]. TB_01_2024.

31. Linezolid Does Not Improve Bactericidal Activity of Rifampin-containing First-line Regimens in Animal Models of TB Meningitis. Tucker, E.W., C.A. Ruiz-Bedoya, F. Mota, C. Erice, J. Kim, P. de Jesus, R. Jahdav, M. Bahr, K. Flavahan, X. Chen, C.A. Peloquin, J.S. Freundlich, and S.K. Jain. International Journal of Antimicrobial Agents, 2024. 63(1): 107048. PMID[38061419]. PMCID[PMC10841818].
[PubMed]. TB_01_2024.

32. The Mycobacterium tuberculosis MmpL3 Inhibitor MSU-43085 Is Active in a Mouse Model of Infection. Williams, J.T., M. Giletto, E.R. Haiderer, B. Aleiwi, T. Krieger-Burke, E. Ellsworth, and R.B. Abramovitch. Microbiology Spectrum, 2024. 12(1): e0367723. PMID[38078724]. PMCID[PMC10783087].
[PubMed]. TB_01_2024.

33. Benzothiozinone Derivatives with Anti-tubercular Activity-further Side Chain Investigation. Wu, X., W. Wang, G. Stelitano, O. Riabova, B. Wang, W. Niu, M. Cocorullo, R. Shi, L.R. Chiarelli, V. Makarov, Y. Lu, C. Li, and C. Qiao. European Journal of Medicinal Chemistry, 2024. 264: 115976. PMID[38039794].
[PubMed]. TB_01_2024.

34. Synthesis and Structure-Activity Relationships of Aryl fluorosulfate-based Inhibitors as Novel Antitubercular Agents. Yang, B., P. Sukheja, B. Qin, G. Li, G.A.L. Bare, A. Cascioferro, M.S. Love, H.M. Petrassi, K.B. Sharpless, C.W. McNamara, and A.K. Chatterjee. Bioorganic & Medicinal Chemistry Letters, 2024. 98: 129596. PMID[38142914]. PMCID[PMC10808981].
[PubMed]. TB_01_2024.

35. Anti-tuberculosis Activity of Morusin: A Promising Flavonoid from White Mulberry. Yildirim, K., S. Bozkurt, H.H. Basibuyuk, and A.Y. Coban. The International Journal of Tuberculosis and Lung Disease, 2024. 28(1): p. 37-41. PMID[38178290].
[PubMed]. TB_01_2024.

Patent Citations

This month, no relevant Mycobacterium patents were identified.